{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T01:06:33Z","timestamp":1788397593595,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Methylation Sciences Inc."}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.jpsychires.2019.11.014","type":"journal-article","created":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T02:48:06Z","timestamp":1574390886000},"page":"118-125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Early score fluctuation and placebo response in a study of major depressive disorder"],"prefix":"10.1016","volume":"121","author":[{"given":"Steven D.","family":"Targum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth R.","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludvina","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. David","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"59 Suppl. l","key":"10.1016\/j.jpsychires.2019.11.014_bib1","first-page":"34","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","author":"Sheehan","year":"1998","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2019.11.014_bib2","doi-asserted-by":"crossref","first-page":"112","DOI":"10.4236\/ojd.2014.33015","article-title":"Does early improvement in anxiety symptoms in patients with major depressive disorder affect remission rates? a post-hoc analysis of pooled duloxetine clinic trials","volume":"3","author":"Altin","year":"2014","journal-title":"Open J. Depress."},{"key":"10.1016\/j.jpsychires.2019.11.014_bib3","series-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)","author":"American Psychiatric Association","year":"1994"},{"issue":"2","key":"10.1016\/j.jpsychires.2019.11.014_bib4","doi-asserted-by":"crossref","first-page":"207","DOI":"10.31887\/DCNS.2006.8.2\/pbech","article-title":"Rating scales in depression: limitations and pitfalls","volume":"8","author":"Bech","year":"2017","journal-title":"Dialogues Clin. Neurosci."},{"issue":"3","key":"10.1016\/j.jpsychires.2019.11.014_bib5","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/sj.bjp.0702589","article-title":"Influence of S-adenosylmethionine on chronic mild stress-induced anhedonia in castrated rats","volume":"127","author":"Benelli","year":"1999","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.jpsychires.2019.11.014_bib6","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1755-5949.2009.00102.x","article-title":"Validation of the Massachusetts general hospital antidepressant treatment history questionnaire (ATRQ)","volume":"16","author":"Chandler","year":"2010","journal-title":"CNS Neurosci. Ther."},{"issue":"1","key":"10.1016\/j.jpsychires.2019.11.014_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1515\/JBCPP.1992.3.1.1","article-title":"Antidepressant activity of S-adenosylmethionine in mice and rats","volume":"3","author":"Czyrak","year":"1992","journal-title":"J. Basic Clin. Physiol. Pharmacol."},{"issue":"5","key":"10.1016\/j.jpsychires.2019.11.014_bib8","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/HRP.0b013e3182a75cc7","article-title":"Massachusetts General Hospital SAFER criteria for clinical trials and research","volume":"21","author":"Desseilles","year":"2013","journal-title":"Harv. Rev. Psychiatry"},{"key":"10.1016\/j.jpsychires.2019.11.014_bib9","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jpsychires.2003.11.006","article-title":"Worsening of depressive symptoms prior to randomization in clinical trials: a possible screen for placebo responders?","volume":"38","author":"Evans","year":"2004","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2019.11.014_bib10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0022-3956(99)00037-0","article-title":"The responsiveness of the Hamilton depression rating scale","volume":"34","author":"Faries","year":"2000","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2019.11.014_bib11","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/00004714-200112000-00004","article-title":"The double blind variable placebo lead-in period: results from two antidepressant clinical trials","volume":"6","author":"Faries","year":"2001","journal-title":"J. Clin. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.jpsychires.2019.11.014_bib12","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000069738","article-title":"The problem of the placebo response in clinical trials for psychiatric disorders: culprits, possible remedies, and a novel study design approach","volume":"72","author":"Fava","year":"2003","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.jpsychires.2019.11.014_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/s41562-019-0732-1","article-title":"Brain regulation of emotional conflict predicts antidepressant treatment response for depression","author":"Fonzo","year":"2019","journal-title":"Nat. Human Behav."},{"key":"10.1016\/j.jpsychires.2019.11.014_bib14","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S2215-0366(16)30307-8","article-title":"Placebo response rates in antidepressant trials: a systematic review of published and unpublished double-blind randomized controlled studies","volume":"3","author":"Furukawa","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"57","key":"10.1016\/j.jpsychires.2019.11.014_bib15","first-page":"1","article-title":"Intrinsic functional connectivity predicts remission on antidepressants: a randomized controlled trial to identify clinically applicable imaging biomarkers","volume":"8","author":"Goldstein-Piekarski","year":"2018","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jpsychires.2019.11.014_bib16","series-title":"EDCEU Assessment Manual for Psychopharmacology \u2013 Revised (DHEW Publ No ADM 76-338). Rockville, MD, U.S. Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration","first-page":"534","author":"Guy","year":"1976"},{"key":"10.1016\/j.jpsychires.2019.11.014_bib17","first-page":"382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Hamilton","year":"1960","journal-title":"Br. J. Psychiatry"},{"issue":"10","key":"10.1016\/j.jpsychires.2019.11.014_bib18","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.4088\/JCP.11r07485","article-title":"Correlation between different levels of placebo response rate and clinical trial outcome in major depressive disorder: a meta-analysis","volume":"73","author":"Iovieno","year":"2012","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.jpsychires.2019.11.014_bib19","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00004714-200202000-00007","article-title":"Severity of depression and response to antidepressants and placebo: an analysis of the Food and Drug Administration database","volume":"22","author":"Khan","year":"2002","journal-title":"J. Clin. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.jpsychires.2019.11.014_bib20","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1017\/S1461145702002912","article-title":"Are placebo controls necessary to test new antidepressants and anxiolytics?","volume":"5","author":"Khan","year":"2002","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2019.11.014_bib21","doi-asserted-by":"crossref","first-page":"464","DOI":"10.4088\/JCP.10m06191","article-title":"Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications","volume":"72","author":"Khin","year":"2011","journal-title":"J. Clin. Psychiatry"},{"issue":"3","key":"10.1016\/j.jpsychires.2019.11.014_bib22","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1027\/2151-2604\/a000176","article-title":"Antidepressants and the placebo effect","volume":"222","author":"Kirsch","year":"2014","journal-title":"Zeitschrift fur Psychologie"},{"key":"10.1016\/j.jpsychires.2019.11.014_bib23","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1371\/journal.pmed.0050045","article-title":"Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration","volume":"5","author":"Kirsch","year":"2008","journal-title":"PLoS Med."},{"key":"10.1016\/j.jpsychires.2019.11.014_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/JCP.0b013e31802eb4b7","article-title":"Why do clinical trials fail? The problem of measurement error in clinical trials: time to test new paradigms?","volume":"27","author":"Kobak","year":"2007","journal-title":"J. Clin. Psychopharmacol."},{"issue":"7","key":"10.1016\/j.jpsychires.2019.11.014_bib25","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0924-9338(01)00600-9","article-title":"The scientific basis and ethical basis for placebo-controlled trials in depression and schizophrenia: an FDA perspective","volume":"16","author":"Laughren","year":"2001","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.jpsychires.2019.11.014_bib26","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/da.10134","article-title":"Does elimination of placebo responders in a placebo run-in increase the treatment effect in randomized clinical trials? A meta-analytic evaluation","volume":"19","author":"Lee","year":"2004","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jpsychires.2019.11.014_bib27","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.jpsychires.2019.11.014_bib28","first-page":"339","article-title":"S-adenosylmethionine and depression","volume":"31","author":"Nguyen","year":"2002","journal-title":"Aust. Fam. Physician"},{"issue":"6","key":"10.1016\/j.jpsychires.2019.11.014_bib29","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1007\/s11920-003-0085-2","article-title":"S-adenosyl-methionine in depression: a comprehensive review of the literature","volume":"5","author":"Papakostas","year":"2003","journal-title":"Curr. Psychiatr. Rep."},{"issue":"8","key":"10.1016\/j.jpsychires.2019.11.014_bib30","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1176\/appi.ajp.2009.09081198","article-title":"S-adenosyl methionine (SAMe) augmentation of serotonin reuptake inhibitors for antidepressant nonresponders with major depressive disorder: a double-blind, randomized clinical trial","volume":"167","author":"Papakostas","year":"2010","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2019.11.014_bib31","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1001\/archpsyc.1984.01790190056007","article-title":"Identification of true drug response to antidepressants","volume":"41","author":"Quitkin","year":"1984","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.jpsychires.2019.11.014_bib32","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1001\/archpsyc.1987.01800150071009","article-title":"Use of pattern analysis to identify true drug response: a replication","volume":"44","author":"Quitkin","year":"1987","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.jpsychires.2019.11.014_bib33","first-page":"191","article-title":"The introductory placebo washout: a retrospective evaluation","volume":"30","author":"Reimherr","year":"1989","journal-title":"Psychol. Res."},{"issue":"2","key":"10.1016\/j.jpsychires.2019.11.014_bib34","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/mpr.79","article-title":"The inventory of depressive Symptomatology (IDS): clinician (IDS-C) and self-report (IDS-SR) ratings of depressive symptoms","volume":"9","author":"Rush","year":"2000","journal-title":"Int. J. Methods Psychiatr. Res."},{"issue":"7","key":"10.1016\/j.jpsychires.2019.11.014_bib36","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1176\/appi.ajp.2012.12040474","article-title":"A model of placebo response in antidepressant clinical trials","volume":"170","author":"Rutherford","year":"2013","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2019.11.014_bib37","first-page":"11","volume":"vol. 3","author":"Sackheim","year":"2003"},{"issue":"3","key":"10.1016\/j.jpsychires.2019.11.014_bib38","doi-asserted-by":"crossref","first-page":"344","DOI":"10.4088\/JCP.07m03780","article-title":"Early improvement in the first 2 weeks as a predictor of treatment outcome in patients with major depressive disorder: a meta-analysis including 6562 patients","volume":"70","author":"Szegedi","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2019.11.014_bib39","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jpsychires.2017.09.009","article-title":"Early symptomatic improvement affects treatment outcome in a study of major depressive disorder","volume":"95","author":"Targum","year":"2017","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2019.11.014_bib40","first-page":"19","article-title":"Early treatment response affects signal detection in a placebo-controlled depression study","volume":"4\u20136","author":"Targum","year":"2017","journal-title":"Pers. Med. Psychiatr."},{"key":"10.1016\/j.jpsychires.2019.11.014_bib41","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1527-3458.2008.00038.x","article-title":"Re-defining affective disorders: relevance for drug development","volume":"14","author":"Targum","year":"2008","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.jpsychires.2019.11.014_bib42","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jpsychires.2018.10.010","article-title":"An augmentation study of MSI-195 (S-adenosylmethionine) in major depressive disorder","volume":"107","author":"Targum","year":"2018","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2019.11.014_bib43","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1192\/bjp.bp.111.093336","article-title":"Assessing the \u2018true\u2019 effect of active antidepressant therapy v. placebo in major depressive disorder","volume":"199","author":"Thase","year":"2011","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2019.11.014_bib44","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/npp.1994.63","article-title":"Does a placebo run-in or a placebo treatment cell affect the efficacy of antidepressant medications?","volume":"11","author":"Trivedi","year":"1995","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2019.11.014_bib45","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jpsychires.2016.03.001","article-title":"Establishing moderators and biosignatures of antidepressant response in clinical care (EMBARC): rationale and design","volume":"78","author":"Trivedi","year":"2016","journal-title":"J. Psychiatr. Res."},{"issue":"7","key":"10.1016\/j.jpsychires.2019.11.014_bib46","first-page":"12","article-title":"Is high placebo response really a problem in depression trials?","volume":"16","author":"Whitlock","year":"2019","journal-title":"Innov. Clin. Neurosci."},{"key":"10.1016\/j.jpsychires.2019.11.014_bib47","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jpsychires.2019.05.023","article-title":"Neural mechanisms of expectancy-based placebo effects in antidepressant clinical trials","volume":"116","author":"Zilcha-Mano","year":"2019","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2019.11.014_bib48","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1176\/appi.ajp.162.7.1370","article-title":"Generalizability of antidepressant efficacy trials: differences between depressed psychiatric outpatients who would or would not qualify for an efficacy trial","volume":"162","author":"Zimmerman","year":"2005","journal-title":"Am. J. Psychiatry"}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395619310957?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395619310957?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T11:14:34Z","timestamp":1758366874000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395619310957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":47,"alternative-id":["S0022395619310957"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2019.11.014","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early score fluctuation and placebo response in a study of major depressive disorder","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2019.11.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}